Navigation Links
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Date:1/15/2009

mpany has a vice president and chief compliance officer, who reports directly to Lilly's chief executive officer; a corporate compliance committee; a code of conduct; policies and procedures specific to promotion and marketing; extensive training; auditing, monitoring and reporting programs, including a compliance hotline; and processes for disciplinary and corrective action.

Also, as part of the settlement, Lilly has entered into a corporate integrity agreement with the Office of Inspector General (OIG) of the U.S. Department of Health and Human Services (HHS). This agreement will require Lilly to maintain its compliance program and to undertake a set of defined corporate integrity obligations for five years. The terms of the corporate integrity agreement are largely consistent with the company's existing compliance program. They also provide for an independent third-party review organization to assess and report on the company's systems, processes, policies, procedures and practices. This agreement reflects Lilly's commitment to continually build on a foundation of compliance, accuracy and transparency.

The settlement is subject to approval by the federal court in Philadelphia; the company anticipates a hearing on the settlement will occur within the next few weeks.

Zyprexa Background

Zyprexa is indicated in the United States for the short- and long-term treatment of schizophrenia, acute mixed or manic episodes of bipolar I disorder, and maintenance treatment of bipolar disorder. Since Zyprexa was introduced in 1996, it has been prescribed for an estimated 26 million patients around the world. Zyprexa is not approved for patients under 18 years of age.

    Zyprexa is not approved for the treatment of patients with dementia-
    ---------------------------------------------------------------------
    related psychosis. Elderly patients with dementia-related psychosis
'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Lilly Files Form 8-K/A Detailing Pro Forma Impact of ImClone Acquisition
2. Lilly Sets Date and Conference Call for Fourth-Quarter and Full-Year 2008 Financial Results Announcement
3. Lilly Announces Dividend Increase
4. Lilly Chairman Taurel Says Promise of Personalized Medicine Could be Jeopardized by Short-Sighted Public Policies
5. Lilly Global Day of Service Receives National and Local Recognition
6. Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
7. Lilly Completes Acquisition of ImClone Systems
8. Lilly Receives NCQA Health Information Product Certification for Interactive Online Health Education Answers Program
9. Lilly Offers Free Health Guide, Available throughout State
10. Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Business Civic Leadership Center
11. Lilly Announces Major Donation of Insulin to International Diabetes Federations Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... MA (PRWEB) December 15, 2014 ... management solutions, announced today that it has received ... Quality Assurance (NCQA) for its Disease Management (DM) ... pulmonary disease (COPD), coronary heart disease and diabetes. ... from NCQA for Health Dialog’s Disease Management (DM) ...
(Date:12/15/2014)... The increase in prevalence of disabling hearing loss in the ... contributing to the growth in the global audiological market. Devices ... loss and balance disorders are known as audiological devices. An ... amplifier. The global market is expected to grow at a ... 2014 to 2019. Some of the factors which are driving ...
(Date:12/15/2014)... In support of high-quality independent peer ... state laws that may have unintended consequences through ... of public health policy. , The position paper, ... Independent Review, contends that state legislation that restricts ... determinations can result in subpar outcomes for both ...
(Date:12/15/2014)... Kenmode Precision Metal Stamping has announced ... of Quality Assurance. He brings more than 15 ... certifications for manufacturers in the U.S. and abroad. ... Manager at Sonoco Products Company in the Protective Solutions ... Quality Assurance Manager for Prince Industries, all in the ...
(Date:12/15/2014)... Colorado (PRWEB) December 15, 2014 Following ... Friday sales, The Grass Station is gearing up for ... one of Colorado’s oldest and largest marijuana dispensaries, began ... sales event that ran through Thanksgiving weekend. , ... then; people are excited,” says Grass Station CEO and ...
Breaking Medicine News(10 mins):Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2Health News:Kenmode Precision Metal Stamping Appoints Abid Rashid as Director of Quality Assurance 2Health News:Colorado’s Grass Station Helps Holiday Shoppers Put Something Special under the Christmas Tree 2
... for individual women in crisis, but advance access to emergency ... pregnancy. ,Contrary to the fears of critics, ... behavior. ,,According to a new review of studies, ... for emergency contraception had an equal chance of becoming pregnant ...
... what many doctors are not aware of is the fact that ... , The research based on around 250 ... Australia showed that many men; ‘straight and happily married’, do ... up as transmitters of HIV/AIDS to their unsuspecting wives, and non-infected ...
... Clinic researchers have designed a new strategy in the promising ... in boosting T cells -- the immune builders akin to ... strategy may prove to be more successful than methods currently ... which was lost to Hurricane Katrina but recovered at Mayo ...
... called upon MPs to support the newly amended Mental Health ... balance between safeguarding patients’ rights as well as ... for the bill, stating that it will serve to bring ... patients. ,As the bill goes to the House ...
... Children of all ages are exposed to TV commercials for junk foods ... study released by the US Kaiser Family Foundation found that children between ... an average of 21 a day or more than 7,600 per year. ... per day or over 6,000 a year, while children aged two to ...
... As researchers from the University of North Carolina mulled ... //have found out that the rhythmic motion of the ... material from the lungs. ,The research published ... could change existing treatment methods for cystic fibrosis. When ...
Cached Medicine News:Health News:Emergency Contraception Does Not Reduce Unintended Pregnancy Rate 2Health News:Emergency Contraception Does Not Reduce Unintended Pregnancy Rate 3Health News:Sleeping With The Enemy 2Health News:Breast Cancer Vaccine Stimulates Potent Immune Response to Cancer Cells 2Health News:Breast Cancer Vaccine Stimulates Potent Immune Response to Cancer Cells 3Health News:Breast Cancer Vaccine Stimulates Potent Immune Response to Cancer Cells 4Health News:Ever-Controversial Mental Health Act To Be Decided Upon 2
(Date:12/15/2014)... Norway , December 15, 2014 ... innovative drugs for aggressive drug resistant cancers, today announces ... in a private placing from new and existing investors. ... financing to support the development of its pipeline of ... program for its lead drug candidate, BGB324, a first-in-class ...
(Date:12/15/2014)... , December 15, 2014 Investor-Edge ... ZGNX ), Eli Lilly and Company (NYSE: ... Sanofi (NYSE: SNY ), and Novartis AG (NYSE: ... can be accessed at: http://investor-edge.com/register . On ... down 1.16%, the Dow Jones Industrial Average lost 1.79%, to ...
(Date:12/15/2014)... BOSTON , December 15, 2014 ... discovery and development company, is pleased to announce the ... United States relating to its GPCR-focused drug ... US significantly strengthens the global patent estate covering Heptares, ... The suite of patents recently granted by the ...
Breaking Medicine Technology:BerGenBio Completes NOK90 Million Fundraising 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2
... Nov. 17 Today, TRACE launched The TRACE Compendium, ... of international anti-bribery enforcement actions and investigations in the ... bring themselves up-to-speed on the latest enforcement trends by ... cases involving gifts and hospitality, cases resulting in the ...
... ALISO VIEJO, Calif., Nov. 17 OCTANe hosted nearly 700 ... discuss promising technology and emerging trends for the medical device ... & Investor Forum. , For the first time on ... Orange County history discussed the details of the deals, and ...
Cached Medicine Technology:TRACE Launches Compendium 2OCTANe's Medical Device & Investor Forum Highlights Key Trends, Investment Opportunities 2
The Cellabs Rapimal (P.f.) is a rapid and sensitive in vitro immunochromatography assay system for the detection of HRP-2 antigen produced by P. falciparum at the merozoite (red blood cell) stage o...
192 Test HRP-II Enzyme Immunoassay for the presence of Plasmodium falciparum infection....
Malaria device / strip (2 line, PAN specific-pLDH)...
... Uni-Gold™ Pf Malaria Test is a ... presence of Plasmodium falciparum ... an antigen-capture assay detecting presence of ... protein II (PfHRP- II), which is ...
Medicine Products: